Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
By Representative Kilcoyne of Clinton, a petition (accompanied by bill, House, No. 1227) of Meghan K. Kilcoyne and others relative to cancer patient access to biomarker testing to provide appropriate therapy. Financial Services.
Introduced
Feb 27, 2025
Last Action
Aug 28, 2025
Session
MA 194th
Sponsors
1 primary · 60 co
Hearing rescheduled to 04/29/2025 from 10:00 AM-01:00 PM in A-2 and Virtual Hearing updated to New End Time
Accompanied a new draft, see H4339
Hearing scheduled for 04/29/2025 from 10:00 AM-02:00 PM in A-2
Senate concurred
Referred to the committee on Financial Services
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Hearing rescheduled to 04/29/2025 from 10:00 AM-01:00 PM in A-2 and Virtual Hearing updated to New End Time
Meghan K. Kilcoyne
Mark J. Cusack
Adrian C. Madaro
Ryan C. Fattman
Richard M. Haggerty
Joshua Tarsky
Adrianne Pusateri Ramos
Danillo A. Sena
Amy Mah Sangiolo
Kristin E. Kassner
Jeffrey Rosario Turco
Tara T. Hong
Steven S. Howitt
Marcus S. Vaughn
Marjorie C. Decker
Margaret R. Scarsdale
Christine P. Barber
Michael P. Kushmerek
Lindsay N. Sabadosa
Natalie M. Higgins
Carole A. Fiola
Brian W. Murray
Jessica Ann Giannino
Edward R. Philips
Paul J. Donato
David Paul Linsky
Bradley H. Jones, Jr.
Thomas M. Stanley
Samantha Montaño
John Francis Moran
Rodney M. Elliott
Steven Ultrino
Michael D. Brady
Jacob R. Oliveira
Natalie M. Blais
William F. MacGregor
Daniel Cahill
James C. Arena-DeRosa
Angelo J. Puppolo, Jr.
Tram T. Nguyen
James Arciero
Paul K. Frost
Kevin G. Honan
Bruce E. Tarr
Steven Owens
Kimberly N. Ferguson
Patrick M. O'Connor
Kathleen R. LaNatra
Richard G. Wells, Jr.